Search company, investor...

Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
radiusventures.com

Investments

82

Portfolio Exits

31

Funds

4

About Radius Ventures

Radius Ventures is a venture capital firm that invests in leading-edge, growth equity and expansion-stage health and life sciences companies. The firm is led by a seasoned group of investment professionals with collective experience across all major sectors of the industry, including medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services and healthcare information technology. Radius takes a hands-on approach with each portfolio company by providing intellectual capital, strategic guidance and access to key industry relationships that ultimately increase the odds of success.

Headquarters Location

250 Park Avenue Suite 1102

New York, New York, 10177,

United States

212-897-7778

Want to inform investors similar to Radius Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Radius Ventures News

EndoGastric Solutions raises $30.5M to commercialize acid reflux treatment

Jul 11, 2018

News Brief: EndoGastric Solutions , a Seattle area biotechnology company, has raised $30.5 million to scale its commercial efforts. Existing investors Advanced Technology Ventures (ATV), Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius Ventures and Sightline Partners took part in the round, along with a number of unnamed new investors. The company — led by former Given Imaging and Abbot Laboratories executive Skip Baldino,  — said in a statement that the cash will support wider commercialization of its treatment for chronic acid reflux, which is already on the market. “This round of funding will enable EGS to continue to expand commercial operations and provide the millions of patients suffering from GERD access to the TIF procedure,” said Baldino in a release . GERD, also known as gastroesophageal reflux disease, is the most common gastrointestinal-related diagnosis, with acid reflux impacting more than 80 million Americans at least once a month, according to estimates. Clare McGrane is a GeekWire reporter who covers life sciences, biotechnology and general assignment technology stories, in addition to producing the GeekWire radio show and podcast. A graduate of the University of Washington, she is passionate about nonfiction storytelling, particularly stories about how science impacts our daily lives. Reach her at clare@geekwire.com and follow her @claremcgrane .

Radius Ventures Investments

82 Investments

Radius Ventures has made 82 investments. Their latest investment was in Amylyx Pharmaceuticals as part of their Series B on July 7, 2020.

CBI Logo

Radius Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/1/2020

Series B

Amylyx Pharmaceuticals

$30M

No

Morningside Ventures, Radius Ventures, and Undisclosed Investors

6

8/22/2016

Series A

Amylyx Pharmaceuticals

$5M

Yes

11

5/26/2015

Series H

EndoGastric Solutions

$50M

No

2

3/3/2015

Series C

Subscribe to see more

$99M

Subscribe to see more

10

8/19/2014

Series E

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/1/2020

8/22/2016

5/26/2015

3/3/2015

8/19/2014

Round

Series B

Series A

Series H

Series C

Series E

Company

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

EndoGastric Solutions

Subscribe to see more

Subscribe to see more

Amount

$30M

$5M

$50M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Morningside Ventures, Radius Ventures, and Undisclosed Investors

Sources

6

11

2

10

10

Radius Ventures Portfolio Exits

31 Portfolio Exits

Radius Ventures has 31 portfolio exits. Their latest portfolio exit was Syft on February 28, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/28/2022

Acquired

$99M

1

1/7/2022

IPO

$99M

Public

6

8/16/2018

Acquired

$99M

3

11/6/2017

Reverse Merger

Subscribe to see more

$99M

Subscribe to see more

10

8/21/2017

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/28/2022

1/7/2022

8/16/2018

11/6/2017

8/21/2017

Exit

Acquired

IPO

Acquired

Reverse Merger

Acq - Fin

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

6

3

10

10

Radius Ventures Fund History

4 Fund Histories

Radius Ventures has 4 funds, including Radius Venture Partners III QP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/17/2007

Radius Venture Partners III QP

$14.25M

1

1/10/2007

Radius Venture Partners III

Subscribe to see more

Subscribe to see more

$99M

10

9/24/2002

Radius Venture Partners II LP

Subscribe to see more

Subscribe to see more

$99M

10

7/31/1997

Radius Venture Partners I LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/17/2007

1/10/2007

9/24/2002

7/31/1997

Fund

Radius Venture Partners III QP

Radius Venture Partners III

Radius Venture Partners II LP

Radius Venture Partners I LP

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$14.25M

$99M

$99M

$99M

Sources

1

10

10

10

Radius Ventures Team

1 Team Member

Radius Ventures has 1 team member, including current Founder, Managing Partner, Jordan S. Davis.

Name

Work History

Title

Status

Jordan S. Davis

KBL Healthcare Ventures, and Morgan Stanley

Founder, Managing Partner

Current

Name

Jordan S. Davis

Work History

KBL Healthcare Ventures, and Morgan Stanley

Title

Founder, Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.